The role of the GABA transporter in acute toxicity in chick retina due to metabolic inhibition was investigated by the use of several substrate (nipecotic acid, THPO) and nonsubstrate (SKF 89976A, NO711) GABA transport inhibitors. Metabolic stress-induced acute toxicity in the retina is characterized by swelling of distinct populations of retinal neurons and selective release of GABA into the medium. Inhibitor concentrations were based on that needed to attenuate 14C-GABA uptake at its approximate KM concentration by _>70%. Under basal conditions, substrate, but not nonsubstrate, inhibitors increased extracellular GABA, but did not cause histological swelling per se. Under conditions of glycolytic inhibition, nonsubstrate, but not substrate, inhibitors significantly attenuated acute toxicity. Metabolic stress-induced acute toxicity was not altered by the GABA agonist muscimol, nor did muscimol reverse the protective effects of nonsubstrate transport inhibitors, suggesting that an increase in extracellular GABA during metabolic stress was not a component of the acute phase of toxicity. The results indicate that during metabolic inhibition, activity at the GABA transporter contributes to acute cellular swelling. © 1997
INTRODUCTION
Impairment of energy metabolism in retina from several species produces damage that is mediated, at least in part, by NMDA receptors (David, Lusky, & Teichberg, 1988; Yoon & Marmor, 1989; Zeevalk & Nicklas, 1991; Mosinger, Price, Bai, Xiao, Wozniak, & Olney, 1991) . Acutely, impairment of either glycolysis or oxidative phosphorylation in chick retina causes swelling of distinct populations of retinal neurons found mainly in the inner layers of the retina, i.e., amacrine cells in the inner half of the inner nuclear layer, cells in the ganglion cell layer and processes in the inner plexiform layer (David et al., 1988; Zeevalk & Nicklas, 1990; Zeevalk & Nicklas, 1991) . This acute swelling is positively correlated with a selective net increase in GABA in the extracellular medium (Zeevalk, Hyndman, & Nicklas, 1989) . Acute swelling (David et al., 1988; Zeevalk & Nicklas, 1990; Zeevalk & Nicklas, 1991) and the increase in extracellular GABA (Zeevalk & Nicklas, 1990; Zeevalk & Nicklas, 1991) Long-term derangements produced by energy impairment in the retina are also attenuated by NMDA (Yoon & Marmor, 1989) . Recently, our laboratory reported that in the chick retina, blocking the GABA transporter with SKF 89976A, a nonsubstrate GABA transport inhibitor attenuated acute GABA release produced by the excitotoxin glutamate (Zeevalk & Nicklas, 1996) . Unexpectedly, SKF 89976A also greatly reduced cellular swelling, suggesting that activity at the GABA transporter during excitotoxin exposure contributes to the acute cellular edema. Since glutamate receptors are involved in acute toxicity produced by inhibition of ene, rgy metabolism in the retina, the present work sought to determine if inhibiting the GABA transporter during energy impairment would attenuate acute damage. To better characterize the role of the GABA transporter in mediation of acute swelling during metabolic inhibition, several substrate and nonsubstrate inhibitors were examined.
MATERIALS AND METHODS

Retinal dissection and incubations conditions during metabolic impairment
Retina were isolated from embryonic (E) day 14/15 White Leghorn chickens as previously described (Zeevalk et al., 1989) . Briefly, retina were isolated in a 3463 bicarbonate buffered Krebs Ringer (KRB) prewarmed to 37°C and pregassed with 5% CO2-95%O2 to adjust the pH to 7.4. KRB consisted of (in raM): 119 NaC1, 4.8 KC1, 25 MOPS buffer, 1.7 CaC12, 1.2 KH2PO4, 1.2 MgSO4, 5.5 glucose, and 23.8 sodium bicarbonate, pH 7.4. Extraocular tissue was removed and the central posterior retina excised. The isolated retina was transferred via a teflon coated spatula to a beaker containing 3 ml of fresh KRB. The tissue was preincubated at 370C with gentle shaking and constant gassing in a Dubnoff Shaker bath for 10 rain, then transferred to fresh KRB and inhibition of glycolysis was initiated by the addition of 1 mM iodoacetate (IOA).
GABA transport inhibitors, SKF89976A (kind gift of SmithKline Beecham, Springhouse, PA), NO711 (RBI, Natick, MA), nipecotic acid (Sigma Chemical Co., St. Louis MO) and 4,5,6,7-tetrahydrois-oxazolol[4,5-c] pyridin-3-ol (THPO, Sigma Chemical Co.), or the GABA agonist muscimol (Sigma Chemical Co.) was present during the preincubation and incubation periods. Incubations with IOA with or without other additives were carried out for 45 rain. At the conclusion of the experiment, the medium was used for GABA determination and the tissue for histology or protein measurement.
C-GABA uptake
Isolated retina were preincubated in KRB at 37°C for 10 min. The medium was removed and replaced with 1 ml KRB plus 14C-(U)-GABA (0.05/~Ci in 5.235/IM total GABA) with or without one of the GABA transport inhibitors: SKF89976A (10, 100#M), NO711 (10, 100/tM), nipecotic acid (0.5, l mM), THPO (3, 10 mM), or the GABAA agonist muscimol (100#M). Uptake was carried out for 10 rain at 37°C. At the end of incubation, the medium was collected, the tissue washed with cold 0.1 M MgCI2 and the radioactivity in the tissue extracted with 0.4 N perchloric acid. Background was determined by measuring t4C-GABA uptake in retina placed on ice for 10min prior to the addition of radioactivity. Background counts were subtracted from all other readings.
GABA determination
At the end of incubation, the medium was acidified with perchloric acid (0.4 N final concentration). Prior to measurement, the samples were neutralized to pH 5.9 with K2CO2. GABA in the medium was quantified by fluorescent detection of the a-phthalaldehyde adduct by HPLC as previously described (Zeevalk et al., 1989) . Protein in the tissue was measured by the procedure of Lowry, Rosebrough, Farr, & Randall (1951) and GABA levels expressed as #mol/100 mg protein (---equivalent to gram of tissue).
Histology
At the end of incubation, retinal tissue was fixed in 3% glutaraldehyde in KRB, dehydrated through a graded series of alcohols and embedded in JB-4 (Polyscience Inc.) under vacuum in flat embedding molds. Five micrometer sections, six per retina were :mounted onto slides and stained with 0.1% cresyl violet for viewing. At least two retina per condition were examined for histology. When GABA levels in the medium were measured from tissue used for histology, an average protein value was used. Protein values raeasured over numerous dissections did not differ by more than 4-10%.
Statistics. Data were analyzed by analy,;is of variance and significance was determined by the Student-Newman Kuels multiple comparisons post hoc test.
RESULTS
Two nonsubstrate GABA transporter inhibitors, SKF89976A and NO711, and two GABA transport inhibitors known to be subgtrates for the transporters, nipecotic acid and THPO, were tested for their ability to inhibit 14C-GABA uptake in isolated E15 chick retina ( Table 1 ). The concentrations reported in Table 1 and then used for subsequent studies were those that provided >_70% inhibition of high affinity GABA uptake.
Consistent with findings from previous studies, inhibition of glycolysis with iodoacetate for 45 rain produced an acute toxicity that was characterized by acute swelling of distinct populations of retinal neurons, most notably, amacrine cells in the inner half of the inner nuclear layer and cells in the ganglion cell layer. Neuritic processes in the inner plexiform layer were acutely swollen, providing a spongy appearance to this retinal layer (Fig. 1 ). Most cells in the outer half of the retina, i.e., bipolar and horizontal cells in the outer half of the inner nuclear layer and photoreceptor cells in the outer nuclear layer were relatively unaffected. As previously demonstrated (Zeevalk & Nicklas, 1990) , acute histological changes were accompanied by a net increase in extracellular GABA (Fig. 2) . The GABA transport inhibitors, SKF 89976A and NO711, which block the transporter but do not act as substrates, provided substantial attenuation of the acute histological swelling (Fig. 1) as well as significant reduction in net extracellular GABA at the conclusion of 45 rain of glycolytic blockade [ Fig. 2(A) ]. In contrast, GABA transport inhibitors that competed with GABA as substrates for the transporter, neither provided protection against the acute cellular swelling (Fig. 1 ) nor the net GABA transport inhibitors such as nipecotic acid, which serve as substrates for the transporter, have been shown to release GABA via a heteroexchange process (Johnston, Stephanson, & Twitchin, 1976; Solis & Nicoll, 1992) . To examine whether this occurred :in retina, and whether reversal of the GABA transporter, under conditions of normal energy metabolism, resulted in acute cellular swelling, El5 retina were :incubated for 
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[OA + THPO FIGURE 2. Matched pairs of isolated E14/15 retina (i.e., left and right retina from the same embryo) were incubated with the glycolytic inhibitor iodoacetate (IOA, 1 mM) for 45 min at 37°C plus either (A) a nonsubstrate GABA transport inhibitor, SKF 89976A (100/~M) or NO711 (100/zM); or (B) a substrate transport inhibitor, nipecotic acid (Nip, l mM) or THPO (10 mM). At the end of incubation, the GABA in the medium was analyzed by HPLC as described in Methods. Nontransported GABA uptake inhibitors (A), but not substrate inhibitors (B) attenuated the IOA-induced rise in extracellular GABA. Basal extracellular GABA levels in this set of experiments were below the level of detection (0.005/zmol/100 mg protein). N is from three to four separate determinations per condition. *Different from IOA alone. P < 0.05 or better, ANOVA with Student-Newman Kuels post hoc test.
45 min in medium containing various transport inhibitors at concentrations that inhibited GABA uptake by >70%: SKF89976A (100/~M), NO711 (100 #M), nipecotic acid (1 mM) or THPO (10 mM). As shown in Fig. 3 , the nonsubstrate transport inhibitors SKF89976A or NO711 did not elevate GABA levels above control, whereas the substrate inhibitors THPO or nipecotic acid significantly elevated extracellular GABA. Nipecotic acid or THPOinduced GABA efflux per se, however, did not result in cellular swelling (Fig. 4) , suggesting that under conditions of normal energy metabolism reversal of the GABA transporter for prolonged intervals was not sufficient to produce acute toxicity. The acute increase in extracellular GABA during the immediate stages following inhibition of energy metabolism may trigger activation of GABAA receptors and result in C1-influx. Acute neuronal swelling during the early stages of excitotoxicity has been shown to be dependent on extracellular CI- (Olney, l:h'ice, Samson, & Labruyere, 1986) . We, therefore, examined whether the increase in extracellular GABA found during metabolic inhibition in retina contributed to acute toxicity by an action at the GABAA receptor. GABA receptor activity during metabolic stress was modulated by incubation with the GABAA receptor agonist, muscimol (100/tM). Muscimol had no effect on high affinity GABA uptake (313 vs 391 + 3.0 pmol/mg protein -t-SEM for Iac-GABA uptake in control and 100/~M muscimol-treated retina, respectively, (n is from two control and three muscimol-treated retinas). As shown in Table 2 and Fig.  4 , activation of the GABAA receptor did not alter acute toxicity produced by IOA treatment. Further, the presence of muscimot was not able to reverse the protective effect of SKF 89976A during IOA treatment ( Table 2) . Histology of retina treated with muscimol plus IOA and SKF 89976A appeared similar to IOA plus SKF 89976A without muscimol (not shown).
DISCUSSION
The major finding from the current work is that the: blockade of the GABA transporter during energy impairment reduces acute cellular swelling and the concomitant increase in extracellular GABA. The findings also demonstrate that the bulk of the GABA released acutely from the retina during metabolic inhibition is a consequence of reversal of the GABA transporter. Previous work has shown that SKF 89976A, a nontransportable GABA uptake inhibitor, blocks acute cell swelling and GABA efflux by glutamate, indicating GABA transporter reversal due to excitotoxicity (Zeevalk & Nicklas, 1996) . Since acute damage in the chick retina during glycolytic inhibition is mediated by NMDA receptors (David et al., 1988; Zeevalk & Nicklas, 1991) , reversal of the transporter during metabolic inhibition is probably a downstream consequence of NMDA receptor involvement. Glutamate mediated-GABA release via reversal of the transporter has been demonstrated in a variety of neuronal cell types (Weiss, 1988; Pin & Bockaert, 1989; Harris & Miller, 1989; Dunlop, Grieve, Schousboe, & Griffiths, 1991; Belhage, Hansen, & Schousboe, 1993) , including retina (Schwartz, 1982; Yazulla & Kleinschmidt, 1983; Jonsson, Lundstrom, Sellstrom, & Ehinger, 1986; Hofmann & Mockel, 1991) and may serve both physiological (Schwartz, 1982) and pathophysiological roles. SKF 89976A, a derivative of nipecotic acid, is not transported by the GABA uptake carrier. It can, however, gain entrance into the cell due to its lip0philicity (Larsson, Falch, Krogsgaard-Larson, & Schousboe, 1988) . Extracellular or intracellular application of SKF 89976A has been shown to block GABA transportermediated currents (Takahashi, Miyoshi, Kaneko, & Copenhagen, 1995) , indicating that SKF 89976A can work on either the trans or cis side of the carrier. Thus, the protective effect of SKF 89976A may be the result of a direct blockade of the transporter from either the extracellular or cytoplasmic surface. The current study does not address the issue of polarity for the action of SKF 89976A. NO711, a lipophilic guavicine derivative had a similar protective effect to SKF 89976A, making it likely that the action of the nonsubstrate GAB A transport blockers was the result of a specific aclion at the transporter. SKF 89976A does not alter glutamateinduced changes in 22Na influx (Zeevalk & Nicklas, 1996) or [Ca]i (Belhage, Hansen, & Schousboe, 1993) . NO711 has been shown to lack affinity for a variety of neurotransmitter receptor or transporter systems (Suzdak, Frederiksen, Andersen, Sorensen, Knutsen, & Nielsen, 1992) , further supporting a specific action of the compounds at the GABA carrier site.
Protection from metabolic stress-induced acute toxicity was found with GABA transport inhibitors that were not substrates for the transporter (SKF 89976A, NO711), whereas uptake inhibitors, such as nipecotic acid and THPO, which are themselves transported and efflux GABA, were not protective. This observation raised the question as to the link between the increase in extracellular GABA and acute cellular edema following excitotoxicity or metabolic inhibition. Both nipecotic acid and THPO caused efflux of GABA into the medium (Fig. 3 ) most likely through a heteroexchange process (Johnston et al., 1976; Solis & Nicoll, 1992) . Nipecotic acid and THPO did not increase GABA efflux above that seen with energy blockade alone. This finding suggests that under conditions of energy block, reversal of the transporter may be occurring at some maximal rate. Under conditions of normal metabolism, the efflux of GABA by nipecotic acid or THPO did not cause cellular swelling. However, the situation may be different with energy compromise or excitotoxicity. Acute swelling resulting from excitotoxicity is known to be Na + and C1-dependent (Olney et al., 1986 ). An increase in extracellular GABA, and activation of GABAA receptors would lead to an increase in C1-conductance, which may further contribute to osmotic imbalance and H20 intake.
To address the role of the increase in extracellular GABA during the acute phase of metabolic inhibition, retina were exposed to the GABA agonist muscimol during glycolytic impairment. Acute toxicity during metabolic impairment was unaltered by the presence of muscimol. In addition, muscimol did not reverse the protective effect of SKF 89976A during metabolic inhibition, which would have been expected if the increase in extracellular GABA was contributing to acute toxicity via activation of GABAA receptors. This finding points to activity at the GABA transporter rather than efflux of GABA per se as being the important mediator in the acute toxic response to metabolic stress. Alternatively, GABAc receptors may also be a source of C1-movement. However, since muscimol is also a potent agonist at GABAc receptors (Buckingham, Hosie, Roush, & Sattelle, 1994) , they seem unlikely to play a role in this regard. More detailed studies with selective agonists are required to further elucidate this point. The ability of nonsubstrate vs substrate transport inhibitors to attenuate cellular edema caused by metabolic stress or excitotoxicity may be related to blockade of the ion flow that accompanies GABA through the transporter. GABA transport requires the presence of Na + and C1-and is electrogenic, but can operate asymmetrically and with variable stoichiometry (Cammack, Rakhilin, & Schwartz, 1994) . Ion movement through the transporter can also occur in the absence of GABA (Cammack et al., 1994) . Further, nonsubstrate inhibitors produce no current themselves and suppress GABA-induced currents, whereas substrate transport inhibitors evoke a current response (Takahashi et al., 1995) , consistent with the interpretation that nonsubstrate inhibitors protect by blocking ionic movements. The transporter may thus be an important source for Na + and C1-movement during excitotoxicity or metabolic stress in retina and may contribute to ionic imbalance and subsequent swelling. Alternatively, energy demands during metabolic derangement may be further compromised by prolonged activity of the transporter trying to clear GABA from the extracellular environment. To this end, blocking the activity of the GABA transporter may help to maintain energy status. This possibility is currently being addressed in the laboratory.
At present, there are four distinct, cloned GABA transporters; GAT-1, GAT-2, GAT-3 and BGT-1 (see Borden, Murali Dhar, Smith, Weinshank, Branchek, & Gluchowski, 1994 for discussion). SKF 89976A, NO711 and nipecotic acid have greater affinity for GAT-1 as compared with the other transporters (Borden et al., 1994) . GAT-1 mRNA has been found in pure neuronal and mixed glial cell cultures (i.e., astrocytes, oligodendrocytes and microglia), but not in pure astrocyte cultures (Gomeza, Gimenez, & Zafra, 1994) . In rat retina, GAT-1 mRNA is expressed in amacrine, displaced amacrine, interplexiforrn cells and some ganglion cells (Brecha & Weigmann, 1994) . Miiller cells also express GAT-1, but at low levels relative to neurons. Honda, Yamamoto, & Saito (1995) demonstrated three subtypes of GABA transporters in rat retina: GAT-1, GAT-2 and GAT-3. GAT-1 was located predominately in the inner part of the inner nuclear layer and the inner plexiform layer, whereas GAT-3 appeared to be primarily associated with Mtiller cells. Thus, it might be speculated that in retina, SKF 89976A, NO711 and nipecotic acid inhibited the GABA transporter found primarily in retinal neurons of the inner layers of the retina. Since the bulk of the increase in extracellular GABA during metabolic stress is from reversal of the transporter, these observations would suggest that the release of GABA is coming predominately from neuronal pools within the inner layers of the retina. THPO is a well known glial specific uptake inhibitor (Schousboe, Hjeds, Krogsgaard-Larsen, & Wood, 1986) . Given that neither THPO (predominately glial) nor nipecotic acid (predominately neuronal) protected against acute toxicity vs metabolic stress, whereas SKF 89976A and NO711 did, the issue of neuronal vs glial uptake inhibition appears less important than whether or not the inhibitor is transported by the carder.
Muscimol, the GABAA agonist had neither a detrimental nor beneficial effect on the acute: toxicity found with metabolic impairment in this model. At very high concentrations (500/~M), muscimol has been shown to inhibit GABA transport in transfected CHO cells (Corey, Guastella, Davidson, & Lester, 1994) . Muscimol at the concentration used in this study (100 #M) did not inhibit GABA uptake, consistent with findings in skate retina (Malchow & Ripps, 1990) and, therefore, any action at this site can be ruled out. Since our studies do not directly assess a physiological effect of muscimol on GABAA receptors, it is possible that the failure of muscimol to modify metabolic stress-induced acute toxicity was due to an ineffective response at the receptor. Several studies have shown that muscimol is an effectiw~ anticonvulsant or protective agent vs stroke/ischemia (Schousboe, Larsson, Wood, & Krogsgaard-Larsen, 1983; Nielsen, Suzdak, Andersen, Knutsen, Sonnewald, & Braestrup, 1991; Shuaib, Mazagri, & Ijaz, 1993; Madden, 1994; Lyden & Lonzo, 1994; Suzdak & Jansen, 1995) . Increasing extracellular GABA would provide protection by hyperpolarizing cells and decreasing activity. One strategy for elevating extracellular GABA levels is by blocking GABA transporters. Nonsubstrate transporters are efficacious anticonvulsants (Nielsen et al., 1991; Suzdak & Jansen, 1995) and have the added advantage over substrate transporters in that they cross the blood-brain barrier more readily due to their lipophilic nature. Although nonsubstrate transport inhibitors do not efflux GABA per se, they block the reuptake of GABA released from other sources to increase extracellular GABA (Waldmeier, Stocklin, & Feldtrauer, 1992) . The use of GABA transport blockers in models of hypoxia/ischemia or hypoglycemia has not been previously addressed. During the initial stages of metabolic stress, swelling of cellular elements can decrease the extracellular space and increase the concentration of potentially excitable extracellular constituents, such as K + or excitatory amino acids. Nonsubstrate GABA transport blockers may have a dual benefit in situations of naetabolic compromise such as stroke/ischemia, hypoxia or hypoglycemia. In addition to hyperpolarizating cells to decrease activity, nonsubstrate blockers would reduce the acute cellular swelling that accompanies metabolic inhibition of neural tissue to further minimize neuronal damage.
